334 related articles for article (PubMed ID: 22700727)
1. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glioma progression by a newly discovered CD38 inhibitor.
Blacher E; Ben Baruch B; Levy A; Geva N; Green KD; Garneau-Tsodikova S; Fridman M; Stein R
Int J Cancer; 2015 Mar; 136(6):1422-33. PubMed ID: 25053177
[TBL] [Abstract][Full Text] [Related]
3. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
Roesch S; Rapp C; Dettling S; Herold-Mende C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions between tumor and its microenvironment in malignant gliomas.
Ellert-Miklaszewska A; Pasierbinska M; Poleszak K; Kamińska B
Postepy Biochem; 2018 Oct; 64(2):129-140. PubMed ID: 30656895
[TBL] [Abstract][Full Text] [Related]
6. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.
Hu F; Ku MC; Markovic D; Dzaye O; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
Int J Cancer; 2014 Dec; 135(11):2569-78. PubMed ID: 24752463
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages.
Carvalho da Fonseca AC; Wang H; Fan H; Chen X; Zhang I; Zhang L; Lima FR; Badie B
J Neuroimmunol; 2014 Sep; 274(1-2):71-7. PubMed ID: 25042352
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fas ligand by microglia: possible role in glioma immune evasion.
Badie B; Schartner J; Prabakaran S; Paul J; Vorpahl J
J Neuroimmunol; 2001 Nov; 120(1-2):19-24. PubMed ID: 11694315
[TBL] [Abstract][Full Text] [Related]
10. CD30 ligand deficiency accelerates glioma progression by promoting the formation of tumor immune microenvironment.
Duan J; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
Int Immunopharmacol; 2019 Jun; 71():350-360. PubMed ID: 30952099
[TBL] [Abstract][Full Text] [Related]
11. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
[TBL] [Abstract][Full Text] [Related]
12. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.
Cantini G; Pisati F; Mastropietro A; Frattini V; Iwakura Y; Finocchiaro G; Pellegatta S
Cancer Immunol Immunother; 2011 Dec; 60(12):1739-50. PubMed ID: 21779877
[TBL] [Abstract][Full Text] [Related]
13. CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia.
Choe CU; Lardong K; Gelderblom M; Ludewig P; Leypoldt F; Koch-Nolte F; Gerloff C; Magnus T
PLoS One; 2011; 6(5):e19046. PubMed ID: 21625615
[TBL] [Abstract][Full Text] [Related]
14. Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of
Pan Y; Xiong M; Chen R; Ma Y; Corman C; Maricos M; Kindler U; Semtner M; Chen YH; Dahiya S; Gutmann DH
Genes Dev; 2018 Apr; 32(7-8):491-496. PubMed ID: 29632086
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.
Gabrusiewicz K; Ellert-Miklaszewska A; Lipko M; Sielska M; Frankowska M; Kaminska B
PLoS One; 2011; 6(8):e23902. PubMed ID: 21901144
[TBL] [Abstract][Full Text] [Related]
16. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.
da Fonseca AC; Badie B
Clin Dev Immunol; 2013; 2013():264124. PubMed ID: 23864876
[TBL] [Abstract][Full Text] [Related]
17. The controversial role of microglia in malignant gliomas.
Wei J; Gabrusiewicz K; Heimberger A
Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
[TBL] [Abstract][Full Text] [Related]
18. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.
Markovic DS; Vinnakota K; Chirasani S; Synowitz M; Raguet H; Stock K; Sliwa M; Lehmann S; Kälin R; van Rooijen N; Holmbeck K; Heppner FL; Kiwit J; Matyash V; Lehnardt S; Kaminska B; Glass R; Kettenmann H
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12530-5. PubMed ID: 19617536
[TBL] [Abstract][Full Text] [Related]
19. Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.
Osterberg N; Ferrara N; Vacher J; Gaedicke S; Niedermann G; Weyerbrock A; Doostkam S; Schaefer HE; Plate KH; Machein MR
Neuro Oncol; 2016 Jul; 18(7):939-49. PubMed ID: 26951383
[TBL] [Abstract][Full Text] [Related]
20. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
